Patent · US Active

Compounds and their uses for alleviating menopause-associated symptoms

US11484539B2 · kind B2 · utility

8Cited by

35References

11Claims

0Family size

Assignee

Estetra SPRL · BE

Inventors

Melanie Taziaux · Liège, BE
Glwadys Rausin · Trooz, BE
Maud Jost · Liège, BE
Marie Mawet · Angleur, BE

Key dates

Filing date	Apr 19, 2019
Grant date	Nov 1, 2022
Priority date	—
Expiry date	Apr 19, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units, for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at a specific daily dose, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.